Email Newsletters

Manufacturing

Acton skate-sharpening company tops Inc. 5000 for New England

An Acton maker of ice skate sharpening equipment is the fastest-growing private company in New England on Inc. magazine's new ranking.

San Antonio manufacturer moves to Spencer

A subsidiary of Spencer-based adhesive coating manufacturer FLEXcon has moved its polymer aerogel production to its parent company’s headquarters. 

Central Mass. stocks up after Trump delays Chinese tariffs

U.S. markets and the stock price of several Central Mass. companies were up Tuesday after the President Donald Trump Administration announced some of the $300 billion in tariffs on Chinese imports will be delayed.

Worcester breweries team up for coffee beer

All five Worcester breweries are teaming up for the first time to release a beer, Snoopy Cap, next month for the first ever Mass Collab on Sept. 21.
ADVERTISEMENT

Pullman Street warehouse sold for $1.05M

Three different entities have acquired an 86,000-square-foot warehouse on Pullman Street in Worcester for $1.05 million. 

Marijuana firm Curaleaf hit with record $250K fine

Wakefield cannabis company Curaleaf, with a majority of its operations in Central Massachusetts, has been fined a record $250,000 by the state Cannabis Control Commission after failing to disclose a change of ownership. 

Standish Executive Search to service marijuana industry

An executive search firm with a recently opened Worcester office has begun working with the growing cannabis industry as marijuana firms have begun building their executive teams in Massachusetts. 

Insulet raises 2019 expectations after 43% Q2 sales bump

Insulet reported a major improvement in its second quarter earnings report, sending its stock price skyrocketing.
ADVERTISEMENT

ReWalk reports decline in revenue despite stroke suit clearances

Despite recent U.S. and European clearances for exoskeleton devices for stroke patients, ReWalk Robotics reported a softer second quarter than expected, sending the company’s stock down nearly 10% on Thursday morning. 

FTC clears Boston Scientific’s $4.2B acquisition

Boston Scientific’s $4.2-billion acquisition of a British cancer and vascular disease firm has been approved by the U.S. Federal Trade Commission, the Marlborough medical device manufacturer disclosed Wednesday. 
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA